Estimating central line-associated bloodstream infection incidence rates by sampling of denominator data: A prospective, multicenter evaluation

American Journal of Infection Control

Volumn 43, Issue 8, 2015, Pages 853-856

  Thompson, Nicola D ^a   Edwards, Jonathan R ^a   Bamberg, Wendy ^b   Beldavs, Zintars G ^c   Dumyati, Ghinwa ^d   Godine, Deborah ^e   Maloney, Meghan ^f   Kainer, Marion ^g   Ray, Susan ^h   Thompson, Deborah ⁱ   Wilson, Lucy ^j   Magill, Shelley S ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Air Pollution Control Division   (United States)

^c OREGON HEALTH AUTHORITY   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

^e CALIFORNIA EMERGING INFECTIONS PROGRAM   (United States)

^f CDC   (United States)

^g TENNESSEE DEPARTMENT OF HEALTH   (United States)

^h Georgia Emerging Infections Program   (United States)

ⁱ NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^j MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

more..

Author keywords

Central line associated bloodstream infection; Denominator; Methods; National Healthcare Safety Network; Surveillance

Indexed keywords

ARTICLE; CATHETER INFECTION; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA COLLECTION METHOD; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EMERGENCY CARE; HOSPITAL; HUMAN; INCIDENCE; INFECTION RATE; LARGE SCALE PRODUCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PROSPECTIVE STUDY; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; EVALUATION STUDY; SEPSIS;

CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; EPIDEMIOLOGIC METHODS; HOSPITALS; HUMANS; INCIDENCE; PROSPECTIVE STUDIES; SEPSIS;

EID: 84938287425     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.03.031     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention. States required by law to report HAI data to NHSN. Available from: http://www.cdc.gov/hai/stateplans/required-to-report-hai-NHSN.html. Accessed August 21, 2014.
2. Centers for Disease Control and Prevention, National Healthcare Safety Network (NHSN). CMS requirements. Available from: http://www.cdc.gov/nhsn/cms/index.html. Accessed August 21, 2014.
3. T.R. Talbot, S.C. Tejedor, R.A. Greevy, H. Burgess, M.V. Williams, J.K. Deshpande, and et al. Survey of infection control programs in a large national healthcare system Infect Control Hosp Epidemiol 28 2007 1401 1403
4. J.P. Burke Infection control: a problem for patient safety N Engl J Med 348 2003 651 656
5. M.A. Shelly, C. Concannon, and G. Dumyati Device use ratio measured weekly can reliability estimated central line-days for central line-associated bloodstream infection rates Infect Control Hosp Epidemiol 32 2011 727 730
6. K.A. Voges, D. Webb, L. Lauren, L.L. Fish, and A.B. Kressel One-day point-prevalence survey of central, arterial, and peripheral line use in adult inpatient Infect Control Hosp Epidemiol 30 2009 606 608
7. J.R. Edwards, D.A. Pollock, B.A. Kupronis, W. Li, J.S. Tolson, K.D. Peterson, and et al. Making use of electronic data: the national healthcare safety network eSurveillance Initiative Am J Infect Control 36 Suppl 2008 S21 S26
8. Centers for Disease Control and Prevention/National Healthcare Safety Network (NHSN). Clinical Document Architecture (CDA). Available from: http://www.cdc.gov/nhsn/CDA/index.html. Accessed December 29, 2014.
9. R.M. Klevens, J.I. Tokars, J.R. Edwards, and T.C. Horan Sampling for collection of central line-day denominators in surveillance of healthcare-associated bloodstream infections Infect Control Hosp Epidemiol 27 2006 338 342
10. N.D. Thompson, J.R. Edwards, W. Bamberg, Z.G. Beldavs, G. Dumyati, D. Godine, and et al. Evaluating the accuracy of sampling to estimate central line-days: simplification of the National Healthcare Safety Network surveillance methods Infect Control Hosp Epidemiol 34 2013 221 228
11. Centers for Disease Control and Prevention. Bloodstream infection event (central line-associated bloodstream infection and non-central line-associated bloodstream infection). Available from: http://www.cdc.gov/nhsn/PDFs/pscManual/4PSC-CLABScurrent.pdf. Accessed March 23, 2015.
12. Centers for Disease Control and Prevention. Meaningful use. Available from: http://www.cdc.gov/ehrmeaningfuluse/introduction.html. Accessed August 21, 2014.
13. Department of Health and Human Services. HIT Policy Committee: request for comment regarding the stage 3 definition of meaningful use of electronic health records (EHRs). Available from: http://www.healthit.gov/sites/default/files/hitpc-stage3-rfc-final.pdf. Accessed August 21, 2014.